Genomic Valley Biotech Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR)
Genomic Valley Biotech Ltd · Financial Result · 14 Aug 2026, 10:05 pm
Genomic Valley Biotech Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR) ■ Revenue: 3,80,000 (-57.8% YoY | +1.3% QoQ) ■ EBITDA: 1,54,162 (-39.4% YoY | +437.4% QoQ) ■ EBITDA Margin (%): 40.6 (+1229 bps YoY | +3292 bps QoQ) ■ PAT: 1,46,162 (-40.7% YoY | Loss to Profit QoQ) ■ EPS (INR): 0.05 (-37.5% YoY | Loss to Profit QoQ)
Original exchange filing (PDF)
More announcements from Genomic Valley Biotech Ltd
- Fintellectual Corporate Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer for the attention of the Public Shareholders of Genomic Valley Biotech .... · 03 Nov 2026
- Please find enclosed herewith unaudited standalone financial results for the quarter and half yearly ended on September 30, 2026 · 30 Oct 2026
- Please find enclosed herewith Outcome of Board Meeting Pursuant to regulation 30 of Sebi (LODR)Regulation, 2015 held on today i.e. 30th October 2026 · 30 Oct 2026
- Fintellectual Corporate Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Detailed Public Statement in terms of Regulation 3(1) and Regulation 4 read with Regulation .... · 27 Oct 2026
- Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve the unaudited financial .... · 30 Oct 2026
- Disclosure under Regulation 30 and Regulation 30A of the SEBI (LODR) Regulations, 2015 regarding Mr. Yogesh Agrawal (hereinafter referred to as the "Promoters" or "Promoter Sellers") of .... · 20 Oct 2026
- Fintellectual Corporate Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Public Announcement ("PA") under Regulation 3(1) and Regulation 4 read with Regulation .... · 19 Oct 2026
- Intimation of approval of Extension of time for holding Annual General Meeting (AGM) of the company for the financial year ended on 31st March 2026, pursuant to regulation 30 of SEBI (Listing .... · 31 Aug 2026
